The Biology of Aging and Related Nuclear Medicine Studies

  • Richard N. PiersonJr.
  • Walton W. Shreeve
Chapter

Abstract

“That time of life though may in me behold when yellow leaves, or none, or few do hang, on those bare choirs where late the sweet birds sang.” Sonnet [53] William Shakespeare

Keywords

Telomere Length Caloric Restriction Free Radical Production Replicative Senescence Proton Leak 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abe T, Tohgi H, Murata T et al (2001) Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer’s disease. Neurosci Lett 312:177–179PubMedGoogle Scholar
  2. Aloia JF, Vaswani A, Yeh JK et al (1994) Calcium supplementation with and without hormone replacement therapy to prevent post-menopausal bone loss. Ann Intern Med 120:97–103PubMedGoogle Scholar
  3. Ames BN, Shigenaga MK (1992) Oxidants are a major contributor to aging. Ann NY Acad Sci 663:85–96PubMedGoogle Scholar
  4. Ames BN, Shigenaga MK, Hagan TM (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 90:7915–7922PubMedGoogle Scholar
  5. Aspnes LE, Lee CM, Weindruch R et al (1997) Caloric restriction reduces fiber loss and mitochondrial abnormalities in aged rat muscle. FASEB 11:573–581Google Scholar
  6. Bartres-Faz D, Junque C, Lopez-Alomar A et al (2001) Neuropsychological and genetic differences between age-associated impairment and mild cognitive impairment entities. J Am Geriatr Soc 49:985–990PubMedGoogle Scholar
  7. Beckman KB, Ames BN (1998) The free radical theory of aging matures. Physiol Rev 78:547–581PubMedGoogle Scholar
  8. Bodnar AG, Ouellette M, Frolkis M et al (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279:349–352PubMedGoogle Scholar
  9. Boss MA (2000) Diagnostic approaches to Alzheimer’s disease. Biochim Biophys Acta 1502:188–200PubMedGoogle Scholar
  10. Boughton B (2002) Instant vertebral assessment. Radiol Today 3:9–11Google Scholar
  11. Braga V, Mottes M, Mirandola S et al (2000) Association of CTR and COLIAl alleles with BMD values in peri-and postmenopausal women. Calcif Tissue Int 67:361–366PubMedGoogle Scholar
  12. Brod SA (2000) Unregulated inflammation shortens human functional longevity. Inflamm Res 49:561–570PubMedGoogle Scholar
  13. Brookes PS, Buckingham JA, Tenreiro AM et al (1998) The proton permeability of the inner membrane of liver mitochondria from ectothermic and endothermic vertebrates and from obese rats: correlations with standard metabolic rate and phospholipid fatty acid composition. Comp Biochem Physiol 119B:325–334Google Scholar
  14. Calder PC, Newsholme EA (1993) Influence of antioxidant vitamins on fatty acid inhibition of lymphocyte proliferation. Biochem Mol Biol Int 29:175–183PubMedGoogle Scholar
  15. Campisi J (1996) Aging cancer: the double edged sword of replicative senescence. Cell 84:497–500PubMedGoogle Scholar
  16. Campisi J (1997) Replicative senescence: an old lives’ tale? J Am Geriatr Soc 45:482–488PubMedGoogle Scholar
  17. Cappa A, Calcagni ML, Villa G et al (2001) Brain perfusion abnormalities in Alzheimer’s disease: comparison between patients with focal temporal lobe dysfunction and patients with diffuse cognitive impairment. J Neurol Neurosurg Psychiatry 70:22–27PubMedGoogle Scholar
  18. Castro E, Edland SD, Lee L et al (2000) Polymorphisms at the Werner locus: II. 1074Leu/Phe, 1367Cys/Arg, longevity, and atherosclerosis. Am J Med Genet 95:374–380PubMedGoogle Scholar
  19. Cefalu WT, Wagner JO, Wang ZQ et al (1997) A study of caloric restriction and aging in cynomolgus monkeys. J Gerontol Biol Sci 52:B10–B19Google Scholar
  20. Cerami A (1985) Hypothesis. Glucose as a mediator of aging. J Am Geriatr Soc 33:626–634PubMedGoogle Scholar
  21. Cerami A (2001) Pharmaceutical intervention of advanced glycation end products discussion 212-216, 217-220 Review 2001. Novartis Found Symp 235:202–212PubMedGoogle Scholar
  22. Charpentier P, Lavenu I, Defebvre L et al (2000) Alzheimer’s disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc HMPAO SPECT data. J Neurol Neurosurg Psychiatry 69:661–663PubMedGoogle Scholar
  23. Chase GD, Rabinowitz JL (1959) Radioisotopes in the Biological Sciences. In: Principles of radioisotope methodology, chap 11. Burgess, Minneapolis, pp 305–328Google Scholar
  24. Cottrell DA, Blakely EL, Johnson MA et al (2001) Mitochondrial DNA mutations in disease and aging. Novartis Foundation Symposium. Wiley, Chichester, pp 234–246Google Scholar
  25. Counsell RE, Schwendner SW, DeForge LE et al (1991) Lipoproteins as carriers for organ-imaging radiopharmaceuticals. Target Diagn Ther 5:251–314Google Scholar
  26. Coux O, Tanaka K, Goldberg AL (1996) Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65:801–847PubMedGoogle Scholar
  27. Cutler RG (1974) Redundancy of information content in the genome of mammalian species as a protective mechanism determining aging rate. Mech Ageing Dev 2:381Google Scholar
  28. Davies KJ (1986) Intracellular proteolytic systems may function as secondary antioxidant defenses: an hypothesis. J Free Rad Biol Med 2:155–173Google Scholar
  29. Davies KJ (2001) Degradation of oxidized proteins by the 20S proteasome. Biochimie 83:301–310PubMedGoogle Scholar
  30. de Lange T (1999) Unlimited mileage from telomerase? Science 283:947–949PubMedGoogle Scholar
  31. de Lange T, Jacks T (1999) For better or worse? Telomerase inhibition and cancer. Cell 98:273–275PubMedGoogle Scholar
  32. De Maeseneer M, Lenchik L, Everaert H et al (1999) Evaluation of lower back pain with bone scintigraphy and SPECT. Radiographics 19:901–912PubMedGoogle Scholar
  33. Drew B, Leeuwenberg C (2002) Aging and the role of the reactive nitrogen species. Ann NY Acad Sci 959:66–81PubMedGoogle Scholar
  34. Dukic-Stefanovic S, Schinzel R, Riederer P et al (2001) AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs? Biogerontology 2:19–34PubMedGoogle Scholar
  35. Effros RB (2001) Ageing and the immune system. Novartis Found Symp. Wiley, New York, pp 130–139Google Scholar
  36. Farlow MR (1998) Etiology and pathogenesis of Alzheimer’s disease. Am J Health Syst Pharm 55[Suppl 2]:S5–S10PubMedGoogle Scholar
  37. Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408:239–247PubMedGoogle Scholar
  38. Fleury C (1997) Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15:269–272PubMedGoogle Scholar
  39. Fox NC, Rossor MN (1999) Diagnosis of early Alzheimer’s disease. Rev Neurol (Paris) 155[Suppl 4]:S33–S37Google Scholar
  40. Fraga CG, Shigenaga MK, Park JW et al (1990) Oxidative damage to DNA during aging: 8-hydroxy-2deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 87:4533–4537PubMedGoogle Scholar
  41. Franceschi C, Bonafe M, Valensin S et al (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann NY Acad Sci 908:244–254PubMedGoogle Scholar
  42. Gaczynska M, Osmulski PA, Ward WF (2001) Caretaker or undertaker? The role of the proteasome in aging. Mech Ageing Dev 122:235–254PubMedGoogle Scholar
  43. Fries JF (1980) Aging, natural death, and the compression of morbidity. N Engl J Med 303:130–135PubMedGoogle Scholar
  44. Galton CJ, Patterson K, Xuereb JH et al (2000) Atypical and typical presentations of Alzheimer’s disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 123:484–498PubMedGoogle Scholar
  45. Ginaldi L, DeMartinis M, D’Ostilio A et al (2000) Cell proliferation and apoptosis in the immune system in the elderly. Immunol Res 21:31–38PubMedGoogle Scholar
  46. Girotti AW (1985) Mechanisms of lipid peroxidation. J Free Radie Biol Med 1:87–95Google Scholar
  47. Gottfries CG, Lehmann W, Regland B (1998) Early diagnosis of cognitive impairment in the elderly with the focus on Alzheimer’s disease. J Neural Transm 105:773–786PubMedGoogle Scholar
  48. Gouze JN, Bianchi A, Becuwe P et al (2002) Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-kappa B pathway. FEBS Lett 510:166–170PubMedGoogle Scholar
  49. Graeber MB, Grasbon-Frodl E, Eitzen UV et al (1998) Neurodegeneration and aging: role of the second genome. J Neurosci Res 52:1–6PubMedGoogle Scholar
  50. Greenstock CL (1993) Radiation and aging: free radical damage, biological response, and possible antioxidant intervention. Med Hypotheses 41:473–482PubMedGoogle Scholar
  51. Guarente L (2000) Sir2 links chromatin silencing, metabolism, and aging. Genes Dev 14:1021–1026PubMedGoogle Scholar
  52. Gutteridge JMC, Halliwell B (1988) The antioxidant proteins of extracellular fluids. In: Chow CK (ed) Cellular antioxidant defense mechanisms. CRC Press, Boca Raton, pp 1–23Google Scholar
  53. Hammer C, Braum E (1988) Quantification of age pigments (lipofuscin). Comp Biochem Physiol B 90:7–17PubMedGoogle Scholar
  54. Hampton MB, Orrenius S (1998) Redox regulation of the caspases during apoptosis. Ann NY Acad Sci 854:328–335PubMedGoogle Scholar
  55. Hardoff R, Braegelmann F, Zanzonico P et al (1993) External imaging of atherosclerosis in rabbits using an 1231-labeled synthetic peptide fragment. J Clin Pharmacol 33:1039–1047PubMedGoogle Scholar
  56. Harley CB (1991) Telomere loss: mitotic clock or genetic time-bomb? Mutat Res 256:271–282PubMedGoogle Scholar
  57. Harman D (1956) Aging: a theory based on free radical and radiation chemistry. J Gerontol 11:298–300PubMedGoogle Scholar
  58. Harman D (1972) The biologic clock: the mitochondria? J Am Geriatr Soc 20:145–147PubMedGoogle Scholar
  59. Harman D (1998) Extending functional life span. Exp Gerontol 33:95–112PubMedGoogle Scholar
  60. Hayflick L (1998) How and why we age. Exp Gerontol 33:639–653PubMedGoogle Scholar
  61. Hayflick L, Moorehead PS (1961) The serial culture of human dip cell strains. Exp Cell Res 25:585–621PubMedGoogle Scholar
  62. Heffner JE, Repine JE (1989) Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 140:531–544PubMedGoogle Scholar
  63. Heininger K (2000) A unifying hypothesis of Alzheimer’s disease. IV. Causation and sequence of events. Rev Neurosci 11:213–328PubMedGoogle Scholar
  64. Herholz K, Bauer B, Wienhard K et al (2000) In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism. J Neural Transm 107:1457–1468PubMedGoogle Scholar
  65. Herrero P, Vedala G, Kowalski R et al (2001) Impact of aging on dobutamide-induced changes in myocardial substrate utilization. J Nucl Med 5[Suppl]:52PGoogle Scholar
  66. Higuchi M, Yanai K, Okamura N et al (2000) Histamine H(l) receptors in patients with Alzheimer’s disease assessed by positron emission tomography. Neuroscience 99:721–729PubMedGoogle Scholar
  67. Hoffman JM, Welsh-Bohmer KA, Hanson M et al (2000) FDG PET imaging in patients with pathologically verified dementia. J Nucl Med 41:1920–1928PubMedGoogle Scholar
  68. Ikebe S, Tanaka M, Ohno K et al (1990) Increase of deleted mitochondrial DNA in the striatum in Parkinson’s disease and senescence. Biochem Biophys Res Commun 170:1044–1048PubMedGoogle Scholar
  69. Ikeda T, Mabuchi A, Fukuda A et al (2001) Identification of sequence polymorphisms in two sulfation-related genes, PAPSS2 and SLC26A2, and an association analysis with knee osteoarthritis. J Hum Genet 46:538–543PubMedGoogle Scholar
  70. Ingram DK, Cutler RG, Weindruch R et al (1990) Dietary restriction and aging: the initiation of a primate study. J Gerontol Biol Sci 45:B148–B163Google Scholar
  71. Ingvarsson T, Stefansson SE, Gulcher JR et al (2001) A large Icelandic family with early osteoarthritis of the hip associated with a susceptibility locus on chromosome 16p. Arthritis Rheum 44:2548–2555PubMedGoogle Scholar
  72. Itahana K, Dimri G, Campisi J et al (2001) Regulation of cellular senescence by p53. Eur J Biochem 268:2784–2791PubMedGoogle Scholar
  73. Jacobson MD, Weil M, Raff MC (1997) Programmed cell death in animal development. Cell 88:347–354PubMedGoogle Scholar
  74. Jazwinski SM (1996) Longevity, genes, and aging. Science 273:54–59PubMedGoogle Scholar
  75. Johnson K, Hashimoto S, Lotz M et al (2001a) Interleukin-1 induces pro-mineralizing activity of cartilage tissue trans-glutaminase and factor XIIIa. Am J Pathol 159:149–163PubMedGoogle Scholar
  76. Johnson KA, Lopera F, Jones K et al (2001b) Presenilin-1-associated abnormalities in regional cerebral perfusion. Neurology 56:1545–1551PubMedGoogle Scholar
  77. Julin P, Almkvist O, Basun H et al (1998) Brain volumes and regional cerebral blood flow in carriers of the Swedish Alzheimer amyloid protein mutation. Alzheimer Dis Assoc Disord 12:49–53PubMedGoogle Scholar
  78. Jurivich DA, Qiu L, Welk JF (1997) Attenuated stress responses in young and old human lymphocytes. Mech Ageing Dev 94:233–249PubMedGoogle Scholar
  79. Justesen J, Stenderup K, Kassem MS (2001) Mesenchymal stem cells. Potential use in cell and gene therapy bone loss caused by aging and osteoporosis. Ugeskr Laeger 163:5491–5495PubMedGoogle Scholar
  80. Lupattelli G, Siepi D, Palumbo B et al (1999) Vascular 1311-low-density lipoprotein imaging in patients with hypertension and early atherosclerotic lesions in the carotid artery. Vasa 28:185–189PubMedGoogle Scholar
  81. Martin JA, Buckwalter JA (2001) Telomere erosion and senescence in human articular cartilage chondrocytes. J Gerontol A Biol Med Sci 56:B172-179Google Scholar
  82. Masoro EJ, Shimokawa I, Yu BPl (1991) Retardation of the aging process in rats by food restriction. Ann NY Acad Sci 621:337–352PubMedGoogle Scholar
  83. Mattson MP, Duan W, Lee J et al (2001) Suppression of brain aging and neurodegenerative disorders by dietary restriction and environmental enrichment: molecular mechanisms. Mech Ageing Dev 122:757–778PubMedGoogle Scholar
  84. Matsunaga H, Tanaka Y, Tanaka M et al (2001) Antiathero-genic mitochondrial genotype in patients with type 2 diabetes. Diabetes Care 24:500–550PubMedGoogle Scholar
  85. Maynard-Smith J (1963) Temperature and the rate of aging in poikilotherms. Nature 199:400–402Google Scholar
  86. Mazzetti I, Grigolo B, Pulsatelli L et al (2001) Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis. Clin Sci 101:593–599PubMedGoogle Scholar
  87. McCay CM, Cromwell MF, Maynard LA (1935) The effect of retarded growth upon the length of life span and upon the ultimate body size. J Nutr 10:63–79Google Scholar
  88. McKelvey R, Bergman H, Stern J et al (1999) Lack of prognostic significance of SPECT abnormalities in non-demented elderly subjects with memory loss. Can J Neurol Sci 26:23–28PubMedGoogle Scholar
  89. Merker K, Stolzing A, Grune T (2001) Proteolysis, caloric restriction, and aging. Mech Ageing Dev 122:595–615PubMedGoogle Scholar
  90. Meydani M (1992) Vitamin E requirement in relation to dietary fish oil and oxidative stress in elderly. EXS 62:411–418PubMedGoogle Scholar
  91. Mielke R, Zerres K, Uhlhaas S et al (1998) Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer’s disease. Neurosci Lett 254:49–52PubMedGoogle Scholar
  92. Miller C, Kelsoe G (1995) Ig VH hypermutation is absent in the germinal centers of aged mice. J Immunol 155:3377–3384PubMedGoogle Scholar
  93. Miquel J (1998) An update on the oxygen stress-mitochondrial mutation theory of aging: genetic and evolutionary implications. Exp Gerontol 33:13–126Google Scholar
  94. Misra RP (2000) Calcium and disease: molecular determinants of calcium crystal deposition diseases. Cell Mol Life Sci 57:421–428PubMedGoogle Scholar
  95. Molero AE, Pino-Ramirez G, Maestre GE (2001) Modulation by age and gender of risk for Alzheimer’s disease and vascular dementia associated with the apolipoprotein Evarepsilon4 allele in Latin-Americans: findings from the Maracaibo Aging Study. Neurosci Lett 307:5–8PubMedGoogle Scholar
  96. Mori A, Utsumi K, Liu J et al (1998) Oxidative damage in the senescence-accelerated mouse. Ann NY Acad Sci 854:239–250PubMedGoogle Scholar
  97. Morris JC (2000) The nosology of dementia. Neurol Clin 18:773–788PubMedGoogle Scholar
  98. Mrak RE, Griffin WS (2000) Interleukin-1 and the immunogenetics of Alzheimer disease. J Neuropathol Exp Neurol 59:471–476PubMedGoogle Scholar
  99. Multhaup G, Ruppert T, Schlicksupp A et al (1997) Reactive oxygen species and Alzheimer’s disease. Biochem Pharmacol 54:533–539PubMedGoogle Scholar
  100. Nagata K, Maruya H, Yuya H et al (2000) Can PET data differentiate Alzheimer’s disease from vascular dementia? Ann NY Acad Sci 903:252–261PubMedGoogle Scholar
  101. Nixon RA (2000) A protease activation cascade in the pathogenesis of Alzheimer’s disease. Ann NY Acad Sci 924:117–131PubMedGoogle Scholar
  102. Nobili F, Copello F, Buffoni F et al (2001) Regional cerebral blood flow and prognostic evaluation in Alzheimer’s disease. Dement Geriatr Cogn Disord 12:89–97PubMedGoogle Scholar
  103. Nobuhara K, Halldin C, Hall H et al (2000) Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer’s disease. Psychopharmacology (Berl) 149:45–55Google Scholar
  104. Ohtsuki K, Hayase M, Akashi K et al (2001) Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradio-graphic study. Circulation 104:203–208PubMedGoogle Scholar
  105. Orgel LE (1963) The maintenance of the accuracy of protein synthesis and its relevance to aging. Proc Natl Acad Sci USA 49:517–521PubMedGoogle Scholar
  106. Pahlavani MA, Harris MD, Richardson A (1997) The increase in the induction of IL-2 expression with caloric restriction is correlated to changes in the transcription factor NFAT. Cell Immunol 180:10–19PubMedGoogle Scholar
  107. Parr T (1997) Insulin exposure and aging theory. Gerontol 43:182–200Google Scholar
  108. Pearl R (1928) The rate of living. Knopf, New YorkGoogle Scholar
  109. Perls TT (2002) Genetic and environmental influences on exceptional longevity and the AGE Nomogram. Ann NY Acad Sci 959:1–13PubMedGoogle Scholar
  110. Pieri C (1991) Food restriction slows down age-related changes in cell membrane parameters. Ann NY Acad Sci 621:353–362PubMedGoogle Scholar
  111. Pincus T (2001) Clinical evidence for osteoarthritis as an inflammatory disease. Curr Rheumatol Rep 3:524–534PubMedGoogle Scholar
  112. Pope A (1733-1734) An essay on man IIGoogle Scholar
  113. Raina AK, Pardo P, Rottkamp CA et al (2001) Neurons in Alzheimer disease emerge from senescence. Mech Ageing Dev 123:3–9PubMedGoogle Scholar
  114. Ramsey JJ, Harper MF, Weindruch R (2001) Restriction of energy intake: energy expenditure and aging. Free Radie Biol Med 29:946–968Google Scholar
  115. Reddel RR (1998) Genes involved in the control of cellular proliferative potential. Ann NY Acad Sci 854:8–19PubMedGoogle Scholar
  116. Reid MB, Durham WI (2002) Generation of reactive oxygen and nitrogen species in contracting skeletal muscle. Ann NY Acad Sci 959:108–116PubMedGoogle Scholar
  117. Richter C, Park JW, Ames BN (1988) Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 85:6465–6467PubMedGoogle Scholar
  118. Rivett AJ (1998) Intracellular distribution of proteasomes. Curr Opin Immunol 10:110–114PubMedGoogle Scholar
  119. Rodewald HR (1998) The thymus in the age of retirement. Nature 396:630–631PubMedGoogle Scholar
  120. Rogaev El (1999) Genetic basis for Alzheimer’s disease and other dementia and prospects of molecular diagnosis (in Russian). Vestn Ross Akad Med Nauk 1:33–39PubMedGoogle Scholar
  121. Rogina B, Reenan RA, Nilsen SP et al (2000) Extended lifespan conferred by cotransporter gene mutations in Drosophila. Science 290:2137–2140PubMedGoogle Scholar
  122. Roth GS, Ingram DK, Lane MA (1999) Calorie restriction in primates: will it work and how will we know? J Am Geriatr Soc 47:896–903PubMedGoogle Scholar
  123. Rubner M (1908) Das Problem der Lebensdauer und seine Beziehungen zum Wachstum und Ernährung. Munich, Oldenburg, pp 150–204Google Scholar
  124. Sacher GA (1968) Molecular versus systemic theories on the genesis of ageing. Exp Gerontol 3:265–271PubMedGoogle Scholar
  125. Salo DC, Lin SW, Pacifici RE et al (1988) Superoxide dismutase is preferentially degraded by a proteolytic system from red blood cells following oxidative modification by hydrogen peroxide. Free Radic Biol Med:335–339Google Scholar
  126. Samani NJ, Boultby R, Butler R et al (2001) Telomere shortening in atherosclerosis. Lancet 358:472–473PubMedGoogle Scholar
  127. Sapolsky RM, Krey LC, McEwen BS (1986) The neuroendo-crinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 7:284–301PubMedGoogle Scholar
  128. Sarikaya I, Sarikaya A, Holder LE (2001) The role of single photon emission computed tomography in bone imaging. Semin Nucl Med 31:3–16PubMedGoogle Scholar
  129. Schamberger RJ, Frost DV (1969) Possible protective effects of selenium against human cancer. Can Med Assoc J 100:682Google Scholar
  130. Schroder J, Buchsbaum MS, Shihabuddin L et al (2001) Patterns of cortical activity and memory performance in Alzheimer’s disease. Biol Psychiatry 49:426–436PubMedGoogle Scholar
  131. Shay JW, Wright WE (2001) Aging. When do telomeres matter? Science 291:839–840Google Scholar
  132. Shouda T, Yoshida T, Hanada T et al (2001) Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest 108:1781–1788PubMedGoogle Scholar
  133. Small GW, Ercoli LM, Silverman DH et al (2000) Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease. Proc Natl Acad Sci USA 97:5696–5698Google Scholar
  134. Sohal RS (1993) The free radical hypothesis of aging: an appraisal of the current status. Aging Clin Exp Res 5:3–17Google Scholar
  135. Sohal RS, Agarwal S, Candas M et al (1994) Effect of age and caloric restriction on DNA oxidative damage in different tissues of C57BL/6 mice. Mech Ageing Dev 76:215–224PubMedGoogle Scholar
  136. Stocks J, Gutteridge GM, Sharp RJ et al (1974) The inhibition of lipid peroxidation by human serum and its relationship to serum proteins and alpha-tocopherol. Clin Sci 47:223–233Google Scholar
  137. Tanaka N, Fukushi K, Shinotoh H et al (2001) Positron emission tomographic measurement of brain acetylcholin-esterase activity using N-[(11)C]methylpiperidin-4-yl acetate without arterial blood sampling: methodology of shape analysis and its diagnostic power for Alzheimer’s disease. J Cereb Blood Flow Metab 21:295–306PubMedGoogle Scholar
  138. Tanaka S, Kawamata J, Shimohama S et al (1998) Inferior temporal lobe atrophy and APOE genotypes in Alzheimer’s disease. X-ray computed tomography, magnetic resonance imaging and Xe-133 SPECT studies. Dement Geriatr Cogn Disord 9:90–98PubMedGoogle Scholar
  139. Tiku ML, Gupta S, Deshmukh DR (1999) Aggrecan degradation in chondrocytes is mediated by reactive oxygen species and protected by antioxidants. Free Radic Res 30:395–405PubMedGoogle Scholar
  140. Van Leeuwen FW, Fischer DF, Kamel D et al (2000) Molecular misreading: a new type of transcript mutation expressed during aging. Neurobiol Aging 21:879–891PubMedGoogle Scholar
  141. Verschure PJ, Van Marie J, Joosten LAB et al (1996) Localization of insulin-like growth factor-1 receptor in human normal and osteoarthritic cartilage in relation to proteo-glycan synthesis and content. Br J Rheum 35:1044–1055Google Scholar
  142. Virgolini I, Rauscha F, Lupattelli G et al (1991) Autologous lowdensity lipoprotein labeling allow characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverage. Eur J Nucl Med 18:948–951PubMedGoogle Scholar
  143. Wallace DC (2001) A mitochondrial paradigm for degenerative diseases and aging Novartis Foundation Symposium. Wiley, Chichester, pp 247–263Google Scholar
  144. Wang E (1997) Regulation of apoptosis resistance and ontogeny of age-dependent diseases. Exp Gerontol 32:471–484PubMedGoogle Scholar
  145. Warner HR (1999) Apoptosis: a two-edged sword in aging. Ann NY Acad Sci 887:1–11PubMedGoogle Scholar
  146. Warner HR, Butler RN, Sprott RL, et al (eds) (1987) Modern biological theories of aging. Raven Press, New YorkGoogle Scholar
  147. Wei YH (1998) Oxidative stress and mitochondrial DNA mutations in human aging. Proc Soc Exp Biol Med 217:53–63PubMedGoogle Scholar
  148. Weindruch R, Kristie JA, Cheney KE et al (1979) Influence of controlled dietary restriction on immunologie function and aging. Fed Proc 38:2007–2016PubMedGoogle Scholar
  149. Weissman A (1942) The duration of life. In: Poulton EB (ed) New paths in genetics. Harper, New YorkGoogle Scholar
  150. Weraarchakul NR, Strong R, Wood WG et al (1989) The effect of aging and dietary restriction on DNA repair. Exp Cell Res 181:197–204PubMedGoogle Scholar
  151. Whitman W (1855) from’ song of myselfGoogle Scholar
  152. Wielopolski L, Vartsky D, Pierson R et al (2000) Gamma resonance absorption. New approach in human body composition studies. Ann NY Acad Sci 904:229–235PubMedGoogle Scholar
  153. Williams GC (1957) Pleiotropy, natural selection, and the evolution of senescence. Evolution 11:398–411Google Scholar
  154. Wu Z, Kinslow C, Pettigrew KD et al (1998) Role of familial factors in late-onset Alzheimer disease as a function of age. Alzheimer Dis Assoc Disord 12:190–197PubMedGoogle Scholar
  155. Yin D (1996) Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. Free Radie Biol Med 21:871–888Google Scholar
  156. Yoshida T, Kuwabara Y, Ichiya Y et al (1998) Cerebral muscarinic acetylcholinergic receptor measurement in Alzheimer’s disease patients on 11C-N-methyl-4-piperidyl benzilate—comparison with cerebral blood flow and cerebral glucose metabolism. Ann Nucl Med 12:35–42PubMedGoogle Scholar
  157. Youngman LD, Park JY, Ames BN (1992) Protein oxidation associated with aging is reduced by dietary restriction of protein or calories. Proc Natl Acad Sci USA 89:9112–9116PubMedGoogle Scholar
  158. Yu BP (1994) Cellular defenses against damage from reactive oxygen species. Physiol Rev 74:139–162PubMedGoogle Scholar
  159. Yu SW, Shaw SM, Van Sickle DC (1999) Radionuclide studies of articular cartilage in the early diagnosis of arthritis in the rabbit. Ann Acad Med Singapore 28:44–48PubMedGoogle Scholar
  160. Zubieta JK, Koeppe RA, Frey KA et al (2001) Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET. Synapse 39:275–287PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • Richard N. PiersonJr.
  • Walton W. Shreeve

There are no affiliations available

Personalised recommendations